Changes in US stocks | Moderna (MRNA.US) rises 5%, and the stock price is approaching a record high

The Zhitong Finance App learned that on Monday, Moderna (MRNA.US) rose more than 8% at the beginning of the session. As of press release, the increase had narrowed beyond 5% to 229.69 US dollars. The stock price was close to an all-time high. According to the news, on October 17, Moderna and MSD collaborated to present the melanoma phase III study on individualized cancer treatment IntiSmeran Autogene combined with Keytruda. Reports indicate that this candidate treatment has made positive progress.